• Bio&Me

  • Sector: Food & Beverage

  • Deal Type : Growth Capital

Bio&Me is a gut-health focussed food brand, selling breakfast products across ambient (granola and porridge) and chilled (yoghurts and kefir) categories via UK supermarkets.

The business was founded in 2019 by Dr Megan Rossi; a renowned gut-health expert and Research Fellow at Kings College and Jon Walsh; an experienced food and beverage leader. The business is chaired by Giles Brooks, a renowned and proven operator with fast growing food and beverage brands.

Bio&Me’s target market is growing quickly as consumer interest in digestive health, driven by wide scientific research into the gut microbiome and its role in overall health and wellness, increases. Experts suggest that this represents a structural change in the market and purchasing decisions.

THE HGL PRIVATE CAPITAL DIFFERENCE:

HGL Private Capital initially invested in Bio&Me in 2024, providing growth capital to support ongoing organic growth.

Since the deal, listing with key customers has increased and sales have improved 75% on the prior year and then also by another 74% in 2025 with a run rate of £20m. Bio&Me is now the fastest growing brand in this space and recently was recognised in The Sunday Times Top 100 Fastest Growing Companies in the UK.

“As our backgrounds are being a Research Fellow at Kings College London and a Marketing Director at Nestle, Dr Megan and I are delighted to welcome HGL Private Capital on board as a key investor in Bio&Me to help strengthen and challenge every element of our plans from a financial and investor point of view.  The fact they are lovely people to work with is the icing on the cake!”

Jon Walsh, CEO of Bio&Me